Christopher Austin, MD, is senior vice president of Research Technologies at GSK, where he is responsible for the identification and validation of novel genetic targets aligned with the core therapeutic areas, and molecules to modulate them.

David Daniel Marina is a senior associate on the Business and Program Development programmatic fundraising team at the Milken Institute.

Sam Hanigan is a associate director in the Milken Institute’s Center for Regional Economics and California Center.

Sruthi Meka is a senior associate at FasterCures at the Milken Institute.